Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Combination therapy when metformin is not an option for type 2 diabetes.

Goldman-Levine JD.

Ann Pharmacother. 2015 Jun;49(6):688-99. doi: 10.1177/1060028015572653. Epub 2015 Mar 13. Review.

PMID:
25770115
2.

Insulin patch pumps: a new tool for Type 2.

Goldman-Levine J.

Diabetes Self Manag. 2014 Mar-Apr;31(2):10, 12, 14. No abstract available.

PMID:
24761543
3.

Twitter as an in-class backchannel tool in a large required pharmacy course.

Camiel LD, Goldman-Levine JD, Kostka-Rokosz MD, McCloskey WW.

Am J Pharm Educ. 2014 Apr 17;78(3):67. doi: 10.5688/ajpe78367. No abstract available.

4.

Canagliflozin: a new drug for type 2.

Goldman-Levine J.

Diabetes Self Manag. 2013 Jul-Aug;30(4):30, 32. No abstract available.

PMID:
23961597
5.

Insulin degludec: a novel basal insulin analogue.

Goldman-Levine JD, Patel DK, Schnee DM.

Ann Pharmacother. 2013 Feb;47(2):269-77. doi: 10.1345/aph.1R351. Epub 2013 Feb 5. Review.

PMID:
23386075
6.

Using integrated learning modules to increase involvement in ASHP student society.

Obua U, Sabackic M, Goldman-Levine J.

Am J Health Syst Pharm. 2012 Feb 15;69(4):277. doi: 10.2146/ajhp110534. No abstract available.

PMID:
22302251
7.

Beyond metformin: initiating combination therapy in patients with type 2 diabetes mellitus.

Goldman-Levine JD.

Pharmacotherapy. 2011 Dec;31(12 Suppl):44S-53S. doi: 10.1592/phco.31.12.44S. Review.

PMID:
22122222
8.

Measuring diabetes care in the national interdisciplinary primary care practice-based research network (NIPC-PBRN).

Dickerson LM, Ables AZ, Everett CJ, Mainous AG 3rd, McCutcheon AM, Bazaldua OV, Weber CA, Carter BL; National Interdisciplinary Primary Care Practice-Based Research Network..

Pharmacotherapy. 2011 Jan;31(1):23-30. doi: 10.1592/phco.31.1.23.

PMID:
21182355
9.

Insulin glargine and cancer risk: an opinion statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy.

Edwards KL, Riche DM, Stroup JS, Goldman-Levine JD, Padiyara RS, Cross LB, Kane MP.

Pharmacotherapy. 2010 Sep;30(9):955-65. doi: 10.1592/phco.30.9.955.

PMID:
20795850
10.

A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control.

Carter BL, Clarke W, Ardery G, Weber CA, James PA, Vander Weg M, Chrischilles EA, Vaughn T, Egan BM; Collaboration Among Pharmacists Physicians To Improve Outcomes Now (CAPTION) Trial Investigators..

Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):418-23. doi: 10.1161/CIRCOUTCOMES.109.908038.

11.

Extended-release venlafaxine-induced alopecia.

Pereira CE, Goldman-Levine JD.

Ann Pharmacother. 2007 Jun;41(6):1084. Epub 2007 May 22. No abstract available.

PMID:
17519298
12.

Ezetimibe/Simvastatin (vytorin) for hypercholesterolemia.

Goldman-Levine JD, Bohlman LG.

Am Fam Physician. 2005 Nov 15;72(10):2081-2. No abstract available.

13.

Insulin detemir--a new basal insulin analog.

Goldman-Levine JD, Lee KW.

Ann Pharmacother. 2005 Mar;39(3):502-7. Epub 2005 Jan 18. Review.

PMID:
15657117
14.

Dramatic worsening of type 2 diabetes mellitus due to olanzapine after 3 years of therapy.

Bechara CI, Goldman-Levine JD.

Pharmacotherapy. 2001 Nov;21(11):1444-7.

PMID:
11714219

Supplemental Content

Loading ...
Support Center